LLY compared with INSM: revenue, margins and what each company keeps, and the suppliers and customers both name

LLYELI Lilly & Co

Mkt capRevenueRevenue

INSMInsmed Inc

Mkt capRevenueRevenue

Compare

LLYELI Lilly & Co

INSMInsmed Inc

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Earnings history

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Earnings history

last 4 reports each · paired by recencyMethod ›

LLY

3 of 4at or beyond implied

Reportimpliedrealized× implied

Q3 FY26±5.1%▲+6.63%×1.29

Q2 FY26±6.2%▲+4.86%×0.79

Q1 FY26±5.3%▲+9.80%×1.85

Feb 4 '26±6.1%▲+10.33%×1.69

INSM2 of 4 reports

2 of 2at or beyond implied

Reportimpliedrealized× implied

Q3 FY26±14.7%▲+15.06%×1.03

Q2 FY26±11.7%▲+33.86%×2.90

= impliedLLY realized, solidINSM realized, hatchedOne scale, both sides: full bar = 34%× = |realized| ÷ impliedspan: LLY 267d · INSM 84dSource: market data

LLYELI Lilly & Co

1,420.90▲+0.70%

Mkt cap$1.3TRevenue$24.4BQ3 FY26Revenue$65.2BFY25

INSMInsmed Inc

106.27▼−2.78%

Regular sessionNov 3 '26

Mkt cap$24.7BRevenue$524MQ3 FY26Revenue$606MFY25

Compare

Regular sessionNov 3 '26

LLYELI Lilly & Co

INSMInsmed Inc

1,420.90▲+0.70%

Price

106.27▼−2.78%

$1.3T

Mkt cap

$24.7B

Q3 FY26$24.4B

Revenue

$524MQ3 FY26

FY25$65.2B

Revenue

$606MFY25

LLY1,420.90▲+0.70%vsINSM106.27▼−2.78%Regular sessionNov 3 '26